Halozyme Therapeutics Inc (NASDAQ:HALO)

37.77
Delayed Data
As of Oct 15
 -0.65 / -1.69%
Today’s Change
27.21
Today|||52-Week Range
56.40
-11.57%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$5.4B

Company Description

There is no company description available for Halozyme Therapeutics Inc.

Contact Information

--
--
-- -- --
P:
Investor Relations:
--

Employees

Chart unavailable

Shareholders

Mutual fund holders59.08%
Other institutional32.76%
Individual stakeholders16.80%

Top Executives

There are no executives to display.